Madarosis.
Khong JJ, Casson RJ, Huilgol SC, Selva D.
Surv Ophthalmol. 2006 Nov-Dec;51(6):550-60. doi: 10.1016/j.survophthal.2006.08.004.
Ocular and eyelid involvement in collagen vascular diseases. Part II. Dermatomyositis, scleroderma, and sarcoidosis.
Santiago S, Enwereji N, Jiang C, Durrani K, Chaudhry S, Lu J.
Clin Dermatol. 2024 Jan-Feb;42(1):9-16. doi: 10.1016/j.clindermatol.2023.10.006. Epub 2023 Oct 31.
ATAXIA-TELANGIECTASIA.
DUNN HG, MEUWISSEN H, LIVINGSTONE CS, PUMP KK.
Can Med Assoc J. 1964 Nov 21;91(21):1106-18.
Ocular involvement in scleroderma.
West RH, Barnett AJ.
Br J Ophthalmol. 1979 Dec;63(12):845-7. doi: 10.1136/bjo.63.12.845.
Linear Scleroderma En Coup de Sabre: A Case Series With Eyelid Involvement and Management.
Kok LT, Malik M, Fayers T, Sorkou K, Issa A, Ezra DG.
Ophthalmic Plast Reconstr Surg. 2025 May-Jun 01;41(3):e80-e85. doi: 10.1097/IOP.0000000000002843. Epub 2024 Dec 10.
Ocular Manifestation in Systemic Sclerosis-A Literature Review.
Paczwa K, Rerych M, Romanowska-Próchnicka K, Różycki R, Gołębiewska J.
Life (Basel). 2024 May 13;14(5):627. doi: 10.3390/life14050627.
Linear scleroderma en coup de sabre affecting the upper eyelid and lashes.
Mears KA, Servat JJ, Black EH.
Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):1097-9. doi: 10.1007/s00417-011-1911-6. Epub 2012 Jan 17.
Ophthalmological manifestations of Parry-Romberg syndrome.
Bucher F, Fricke J, Neugebauer A, Cursiefen C, Heindl LM.
Surv Ophthalmol. 2016 Nov-Dec;61(6):693-701. doi: 10.1016/j.survophthal.2016.03.009. Epub 2016 Apr 1.
Histopathologic Findings of Linear Scleroderma Displaying Focal Trichiasis Secondary to Tarsal Thinning.
Reshef ER, Wolkow N, Jakobiec FA, Yoon MK.
Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4):e124-e127. doi: 10.1097/IOP.0000000000001140.
Pellucid marginal degeneration and scleroderma.
Sii F, Lee GA, Sanfilippo P, Stephensen DC.
Clin Exp Optom. 2004 May;87(3):180-4. doi: 10.1111/j.1444-0938.2004.tb03172.x.
